| Bioactivity | Senaparib hydrochloride (IMP4297 hydrochloride) is an oral, selective PARP1/2 inhibitor with potent anti-tumor activity. Senaparib hydrochloride shows antitumor activity against advanced ovarian cancer[1]. |
| CAS | 1401683-39-3 |
| Formula | C24H21ClF2N6O3 |
| Molar Mass | 514.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. P. de Souza, et al. 574P Updated results of phase I study of senaparib (IMP4297) in Australian patients with advanced solid tumours. ABSTRACT ONLY| VOLUME 31, SUPPLEMENT 4, S490, SEPTEMBER 01, 2020. [2]. Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial |
Senaparib hydrochloride
CAS: 1401683-39-3 F: C24H21ClF2N6O3 W: 514.91
Senaparib hydrochloride (IMP4297 hydrochloride) is an oral, selective PARP1/2 inhibitor with potent anti-tumor activity.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.